ArticlePublic health reviews2022

Barriers and Facilitators in Access to Diabetes, Hypertension, and Dyslipidemia Medicines: A Scoping Review.

Carla Castillo-Laborde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.